Market Insights
The report titled “Global Endoscopic Vessel Harvesting Systems Market: Growth, Future Prospects, and Competitive Analysis, 2016–2023” offers strategic insights into the Global Endoscopic Vessel Harvesting Systems and market size and estimates for the duration 2013–2023. The said research study covers an in-depth analysis of multiple market segments based on the type of application and different geographies.
Endoscopic vessel harvesting, developed in 1996, is gaining popularity due to its minimally invasive procedure, which requires a small incision and is a safer surgical process that promotes earlier recovery.
The EVH reduces the possibility of wound infection complications and infection, thus reducing tissue damage and surgical trauma for the patient. Almost 80% of coronary artery bypass grafting procedures in the U.S. are performed using EVH, which is considered the standard of care. Since its introduction, EVH technology has undergone several transformations, and the manufacturers have introduced refinements to make EVH procedures easier, faster, and safer. While device manufacturers have perpetually introduced product innovations, surgeons have also developed improved clinical practices as their experience increased over time.
North America dominated the overall market in terms of revenue share and was expected to continue its dominance throughout the forecast period. The key factors assisting the growth of the endoscopic vessel harvesting system market are the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and incessant technological development in endoscopic vessel harvesting systems.
For the purpose of this study, the global endoscopic vessel harvesting systems market is segmented on the basis of a brand into VirtuoSaph, Vasoview 6 Pro, Vascuclear, Cardio Vision, and Endoperfect System. Market size estimates and forecasts for these segments for the period 2013–2023 are provided in terms of USD million, along with the respective compounded annual growth rates (CAGRs) for the period 2016–2023, considering 2015 as the base year.
The geographical segmentation of the global endoscopic vessel harvesting systems market comprised regions such as North America, Europe, Asia-Pacific, Latin America & the Middle East, and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Brazil, and GCC countries. The market size and forecast for these segments during 2013–2023 and their CAGRs for the period 2016–2023 are provided in this report.
The global endoscopic vessel harvesting systems market is observed as a highly concentrated and competitive market with a limited number of companies operating. The key players in this market are MAQUET Holdings, Terumo Corporation, LivaNova plc., Med Europe S.r.l., and Cardio Medical GmbH.
Based on the type of brand, the global endoscopic vessel harvesting systems market is segmented as follows:
- VirtuoSaph Plus
- MAQUET EVH Systems
- vascular
- Cardio Vision
- Venapax
- Endoperfect System
Overall, the EVH market is specifically concentrated, with a limited number of products in circulation. Such commercially available systems are equipped with proprietary technologies and methods of operation. Terumo Cardiovascular introduced the VirtuoSaph Plus endoscopic vessel harvesting system in 2012 in the U.S. market after receiving FDA approval. VirtuoSaph Plus has improved recyclable packaging that features a tray-in-tray design, thus offering swift access to the sterile tray and an ergonomic grip for better device circulation. MAQUET has come with refined technology and robust design to address the unmet needs of cardiac surgeons with a range of VASOVIEW EVH systems such as VASOVIEW
HEMOPRO 2, VASOVIEW HEMOPRO, VASOVIEW7, and VASOVIEW 6 PRO The VASOVIEW HEMOPRO 2 Endoscopic Vessel Harvesting (EVH) System represents the ideal standard in visualizing and maneuvering to harvest the saphenous vein and radial artery. It enables the surgeon to cut and seal the vessels, thus giving a better surgical outcome. VASOVIEW HEMOPRO has a unique thermostatic tip that helps in one smooth motion cut and seal, less than 1mm, which maintains the hemostasis in surrounding tissue. It provides the harvester with clear vision and visualization in the tunnel with proximal and distal CO2 insufflation.
It provides hands-on control, which helps with sensitivity and responsiveness. The VASOVIEW 7 EVH System provides optimum maneuverability to harvest the saphenous vein or radial artery and clear visibility due to proximal and distal CO2 insufflation. VASOVIEW 6 PRO provides a large cutting toggle, rotating carriage, and C-Ring slider, which improves control and facilitates easy operation to maintain the quality of care. Saphena, a spinoff of Pavilion Medical Innovations of Catalyst Health Ventures that raised Series B funding, has come up with the Venapax Endoscopic Vessel Harvesting System. Vimax holds a flexible tip that stays closed during dissection and expands when electrodes are deployed.
The electrodes can be easily deployed or retracted as needed during dissection. The endoscopic vessel harvesting system market is highly concentrated and competitive, with a limited number of companies operating that are bursting with novel products to ease the use of technology while increasing precision and maintaining the quality of care.
For the purpose of this study, the global endoscopic vessel harvesting systems market is categorized into three segments:
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
In the base year 2015, North America accounted for the largest share in terms of 36%, of which the U.S. occupies a major part, mainly due to key drivers such as standard devices for vein harvesting, rising demand for minimally invasive surgeries, and being considered one of the more cost-effective procedures.
Other driving factors include the aging population, the increasing prevalence of cardiovascular diseases, and increased awareness and preference related to gold-standard surgery systems. On the other hand, the Asia-Pacific market is expected to grow at a CAGR of 8.6% throughout the forecast period of 2016 to 2023.
The major factors assisting the exponential growth of this region are the high growth of the geriatric population, awareness programs among surgeons, the rising prevalence of cardiovascular diseases, and the rising demand for minimally invasive and cost-efficient surgery.
Heart diseases are on the rise in Asia, and among Asian countries, Australia has one of the highest incidences of cardiac surgery procedures. The number of coronary artery bypass graft (CABG) procedures in Australia is similar to that of Japan, a country with almost six times the number of people. Regardless of the number of procedures performed per country, the demand for CABG is expected to grow in Asia.
